LUDI Therapeutics Secures Seed Funding from Sport Horizon Holding to Push the Boundaries of Medical Innovation in Sports-Related Injuries
LUDI Therapeutics is a regenerative medicine biotech company based in Monaco dedicated to developing treatments for sports injuries. Today, LUDI Therapeutics is thrilled to announce that it has secured seed investment from Sport Horizon Holding to tackle muscle injuries. Sport Horizon Holding is an innovative hub investing in the most promising and visionary startups that will make a profound and sustainable impact in the sport industry.
Muscle injuries are extremely frequent in both sport and at work (> 60 million muscle injuries per year worldwide require medical intervention). The treatment of muscle injuries is a real challenge with long-term deficits in muscle structure and strength remaining an unmet clinical need.
Romy Gai, Chairman of AWE Sport International Group and former Chief Revenue Officer and Marketing Director of the Juventus Football Club said, “During my career, I witnessed first-hand the impact of muscle injuries on an athlete's career and how muscle injuries hurt sport institutions. The approach taken by LUDI Therapeutics is truly innovative and could be a game changer in our industry.”
Russell Steves, Physical Therapist, LUDI Therapeutics Medical Advisor and former Head Athletic Trainer the New York Red Bulls said, "Muscle injuries continue to confound us in professional sports medicine. They result in millions of dollars lost in player availability in addition to tremendous frustration by all parties. This is prompting a major overhaul in how we think about muscle injuries as well as how we treat and prevent them. Our current methods need improvement. Innovations are coming which make LUDI Therapeutics' effort to find novel solutions very exciting."
Cindy Benod, Founder/CEO of LUDI Therapeutics said, “LUDI Therapeutics’ mission is to develop cutting-edge science-based treatments for muscle injuries. Our first-in-class therapeutics will enhance the natural healing process after muscle injury and avoid long term complications responsible for recurrence of such injuries.”
Sport Horizon Holding are an investment holding whose mission is the importance of looking towards the future. We scan the horizon for what is yet to come on both the entertainment and performance sides.
For LUDI Therapeutics, partnering with Sport Horizon Holding and having access to key sport stakeholders is a true testament to the continued need for innovation in muscle injury treatment.
Juli Ferré Nadal, Managing Director of LUDI Therapeutics and former Head of Global Sponsorship for FC Barcelona added, "We are delighted to team up and have the support and funding of the forward-thinking minds of Sport Horizon Holding to join LUDI at this exciting time in our early research and development efforts of transformative muscle injury solutions. We see the involvement of the sports community as a key to our success, and this is a magnificent first step to make significant changes in the world of sport medicine.”
Paolo Zaglia – International Private Client Advisor / President of Sport Horizon Holding’s Investment Committee: When we first learnt about LUDI Therapeutics’ vision and purpose, the whole committee was immediately able to relate to the dream scenario where this therapy was already available, benefitting millions of sport practitioners. Supporting this early stage of research for such a visionary solution to sport muscle injury is a very good example of the projects we like to back for their potential global impact on the life of many.
Dario Montagnese – Managing General partner: LUDI represents the first investment for us, and therefore the official starting point of our investment cycle. We believe the company will outperform the sector comparables thanks to its team and groundbreaking innovation. The speed at which we are deploying the capital is the proof of our ability to execute in a quick and efficient manner. I firmly believe that besides our industry expertise this element is one of our major strengths as execution is the key to generating consistent returns in venture capital.
Guillaume Poncet-Montange, Co-Founder and scientific advisor of LUDI Therapeutics said, “We are convinced that regenerative medicine will provide the treatments of tomorrow that will allow EVERYONE to practice sports and engage in physical exercise at all stages of their life.”
________________________________________________________________________________________
|
For media enquiries about LUDI Therapeutics: Contact: Celine Brill, Head of Marketing + Communications |
About LUDI Therapeutics
LUDI Therapeutics is an innovative drug discovery biotech company based in Monaco. It is a pioneer in bridging the world of sports and biotech. LUDI Therapeutics is made up of a multi-disciplinary team that combines the world's leading experts in elite sports, sport medicine, drug discovery and regenerative medicine to create the breakthrough drugs to heal physical injuries. The company’s most advanced program focuses on enhancing the healing process after a muscle injury.
For media enquiries about Sport Horizon Holding:
Contact:
Dario Montagnese,
Partner
About Sport Horizon Holding
Sport Horizon Holding are an investment holding whose mission is the importance of looking towards the future. We scan the horizon for what is yet to come on both the entertainment and performance sides.